The Library
The interaction of vasopressin and corticosteroids in septic shock
Tools
Tools
Tools
Gordon, Anthony C., Mason, Alexina J., Perkins, Gavin D., Stotz, Martin, Terblanche, Marius, Ashby, Deborah and Brett, Stephen J. (2014) The interaction of vasopressin and corticosteroids in septic shock. Critical Care Medicine, 42 (6). pp. 1325-1333. doi:10.1097/ccm.0000000000000212 ISSN 0090-3493.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://dx.doi.org/10.1097/ccm.0000000000000212
Abstract
Objectives: Vasopressin and corticosteroids are both commonly used adjunctive therapies in septic shock. Retrospective analyses have suggested that there may be an interaction between these drugs, with higher circulating vasopressin levels and improved outcomes in patients treated with both vasopressin and corticosteroids. We aimed to test for an interaction between vasopressin and corticosteroids in septic shock.
Design: Prospective open-label randomized controlled pilot trial.
Setting: Four adult ICUs in London teaching hospitals.
Patients: Sixty-one adult patients who had septic shock.
Interventions: Initial vasopressin IV infusion titrated up to 0.06 U/min and then IV hydrocortisone (50 mg 6 hourly) or placebo. Plasma vasopressin levels were measured at 6-12 and 24-36 hours after hydrocortisone/placebo administration.
Measurements and Main Results: Thirty-one patients were allocated to vasopressin + hydrocortisone and 30 patients to vasopressin + placebo. The hydrocortisone group required a shorter duration of vasopressin therapy (3.1 d; 95% CI, 1.1-5.1; shorter in hydrocortisone group) and required a lower total dose of vasopressin (ratio, 0.47; 95% CI, 0.32-0.71) compared with the placebo group. Plasma vasopressin levels were not higher in the hydrocortisone group compared with the placebo group (64 pmol/L difference at 6- to 12-hour time point; 95% CI, -32 to 160 pmol/L). Early vasopressin use was well tolerated with only one serious adverse event possibly related to study drug administration reported. There were no differences in mortality rates (23% 28-day mortality in both groups) or organ failure assessments between the two treatment groups.
Conclusions: Hydrocortisone spared vasopressin requirements, reduced duration, and reduced dose, when used together in the treatment of septic shock, but it did not alter plasma vasopressin levels. Further trials are needed to assess the clinical effectiveness of vasopressin as the initial vasopressor therapy with or without corticosteroids.
| Item Type: | Journal Article | ||||
|---|---|---|---|---|---|
| Subjects: | R Medicine > R Medicine (General) | ||||
| Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Clinical Trials Unit Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||
| Journal or Publication Title: | Critical Care Medicine | ||||
| Publisher: | Lippincott Williams and Wilkins | ||||
| ISSN: | 0090-3493 | ||||
| Official Date: | 1 June 2014 | ||||
| Dates: |
|
||||
| Volume: | 42 | ||||
| Number: | 6 | ||||
| Page Range: | pp. 1325-1333 | ||||
| DOI: | 10.1097/ccm.0000000000000212 | ||||
| Status: | Peer Reviewed | ||||
| Publication Status: | Published | ||||
| Access rights to Published version: | Restricted or Subscription Access | ||||
| Funder: | UK Intensive Care Foundation, National Institute for Health Research (Great Britain) (NIHR), Guys and St Thomas' NHS Foundation Trust and Kings College London | ||||
| Grant number: | NIHR/CS/009/007 |
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
